Neglected Tropical Diseases (NTDs) represent a group of 20 pathologies that are classified by the World Health Organization (WHO) as such due to their medicinal and societal impact. They are endemic in 149 countries, mainly in tropical and subtropical areas, and are highly associated with poverty. These diseases affect hundreds of millions of people worldwide with significant morbidity and/or mortality. In addition, they are neglected by research since most of the drugs currently in use for their treatment, are old with various limitations such as low efficacy, high toxicity, emergence of parasite resistance, difficulties in patient compliance, and high cost.
The group, through COST action “One Health drugs against parasitic vector borne diseases in Europe and beyond”, aspires to contribute to the enrichment of compound libraries through the synthesis of new heterocyclic compounds as potent anti-malarial and anti-trypanosomatid agents.